Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma

PURPOSE: Patient-derived organoids (PDO) of lung cancer has been recently introduced, reflecting the genomic landscape of lung cancer. However, clinical relevance of advanced lung adenocarcinoma organoids remains unknown. Here, we examined the ability of PDOs to predict clinical responses to targete...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seok-Young, Kim, Sang-Min, Lim, Sumin, Lee, Ji Yeon, Choi, Su-Jin, Yang, San-Duk, Yun, Mi Ran, Kim, Chang Gon, Gu, Seo Rin, Park, Chaewon, Park, A-Young, Lim, Sun Min, Heo, Seong Gu, Kim, HyunKi, Cho, Byoung Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2021
Materias:
Translational Cancer Mechanisms and Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401503/
https://www.ncbi.nlm.nih.gov/pubmed/34083237
http://dx.doi.org/10.1158/1078-0432.CCR-20-5026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401503/
https://www.ncbi.nlm.nih.gov/pubmed/34083237
http://dx.doi.org/10.1158/1078-0432.CCR-20-5026

Ejemplares similares